Concepedia

Padmaja Yerramilli-Rao

PY

Statistics

Publications

11

Citations

542

H-Index

10

Active since

2010

Affiliations

Institut Curie(Current)

Leiden University Medical Center

Memorial Sloan Kettering Cancer Center

Columbia University Irving Medical Center

Novartis (United States)

Padmaja Yerramilli-Rao is an author at Institut Curie specializing in medicine, oncology, and cancer cell biology.

Top concepts

Publications per year

2010–2023

11

Publications

11

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies

Patrick Schöffski, Daniel Shao-Weng Tan, Miguel Martín et al. · Journal for ImmunoTherapy of Cancer · 2022 · 147 citations · Full text

Depression in amyotrophic lateral sclerosis

Nazem Atassi, Amanda Cook, Cristiana M. Pineda et al. · Amyotrophic Lateral Sclerosis · 2010 · 90 citations

, , +11

Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071

Sophie Piperno‐Neumann, James Larkin, Richard D. Carvajal et al. · Molecular Cancer Therapeutics · 2020 · 61 citations

Phase I dose-escalation study of the protein kinase C (PKC) inhibitor AEB071 in patients with metastatic uveal melanoma.

Sophie Piperno‐Neumann, Ellen Kapiteijn, James Larkin et al. · Journal of Clinical Oncology · 2014 · 54 citations

, , +17

A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma

Sophie Piperno‐Neumann, Matteo S. Carlino, Valentina Boni et al. · British Journal of Cancer · 2023 · 54 citations · Full text

1–5 of 11